Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)

China · Delayed Price · Currency is CNY

24.99

-0.30 (-1.19%)

Jun 2, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Blood Products	1.11B	1.07B	985.02M	653.93M	889.29M
Blood Products Growth	3.43%	8.80%	50.63%	-26.47%	-0.54%
Property Lease	141.56M	120.97M	34.52M	-	-
Property Lease Growth	17.02%	250.44%	-	-	-
Unallocated Other Industry	16.66M	10.54M	28.96M	-	18.14M
Unallocated Other Industry Growth	58.06%	-63.61%	-	-	73.48%
Other	-	-	-	14.00M	-
Total	1.27B	1.20B	1.05B	667.93M	907.43M
Total Growth	5.28%	14.75%	56.98%	-26.39%	0.32%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	1.27B	1.20B	1.05B	667.93M	907.43M
China Growth	5.28%	14.75%	56.98%	-26.39%	0.32%
Total	1.27B	1.20B	1.05B	667.93M	907.43M
Total Growth	5.28%	14.75%	56.98%	-26.39%	0.32%

Source: S&P Global Market Intelligence.